New strategy to attack aggressive brain cancer shows promise
WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Related articles
Independent UN experts urge Yemen’s Houthis to free detained Baha'i followers
CAIRO (AP) — Human rights experts working for the United Nations on Monday urged Yemen’s Houthi rebe2024-05-21VOX POPULI: Nikkei index soars but real economy still feels sluggish
When watching a Hollywood movie, the first thing you see is the production logo, the “face” of the f2024-05-21VOX POPULI: Manga artist exposes the juicy dynamics behind ‘oden’ factions
Factions are essentially about “hanging around together with buddies,” manga artist Sadao Shoji obse2024-05-21Education Ministry workers on tenterhooks awaiting job cuts news
Education Ministry workers say they have been kept nervously waiting while leaders delay revealing t2024-05-21NBA playoffs: Edwards leads Wolves to 98
DENVER (AP) — Anthony Edwards overcame a slow start and the Timberwolves roared back from a 20-point2024-05-21VOX POPULI: The power of old photos and a deficit
A photograph can bring the past back to life.Even if it’s black and white, the picture is in vivid c2024-05-21
atest comment